Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.

dc.contributor.authorYalcin, Suayib
dc.contributor.authorDane, Faysal
dc.contributor.authorOksuzoglu, Berna
dc.contributor.authorYildirim, Nuriye
dc.contributor.authorIsikdogan, Abdurrahman
dc.contributor.authorOzkan, Metin
dc.contributor.authorDemirag, Guzin
dc.contributor.authorCoskun, Hasan Senol
dc.contributor.authorKarabulut, Bulent
dc.contributor.authorEvrensel, Turkkan
dc.contributor.authorUstaoglu, Mehmet Ali
dc.contributor.authorOzdemir, Feyyaz
dc.contributor.authorTurna, Hande
dc.contributor.authorYavuzsen, Tugba
dc.contributor.authorAykan, Faruk
dc.contributor.authorSevinc, Alper
dc.contributor.authorAkbulut, Hakan
dc.contributor.authorYuce, Deniz
dc.contributor.authorHayran, Mutlu
dc.contributor.authorKilickap, Saadettin
dc.date.accessioned2019-10-27T10:42:20Z
dc.date.available2019-10-27T10:42:20Z
dc.date.issued2018
dc.departmentEge Üniversitesien_US
dc.descriptionGastrointestinal Cancers Symposium -- JAN 18-20, 2018 -- San Francisco, CAen_US
dc.identifier.doi10.1200/JCO.2018.36.4_suppl.346
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue4en_US
dc.identifier.urihttps://doi.org/10.1200/JCO.2018.36.4_suppl.346
dc.identifier.urihttps://hdl.handle.net/11454/30692
dc.identifier.volume36en_US
dc.identifier.wosWOS:000436174100331en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleQuality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.en_US
dc.typeConference Objecten_US

Dosyalar